Sinopsis
ReachMD brings you the latest research, announcements, and conversations from the most important medical conferences around the world. Join us on the conference floor with keynote speakers, experts, and opinion leaders.
Episodios
-
Hepatitis B Reactivation in HIV: A Recap of Data from IDWeek 2023
18/10/2023Host: Rachel Denyer, MD About one in every three people living with HIV has a positive hepatitis B core antibody. But how frequently does hepatitis B reactivation occur after a patient with HIV switches to an antiretroviral regimen that has no hepatitis B activity? Find out with Dr. Rachel Denyer as she shares key data she presented at IDWeek 2023 in the session titled “Hepatitis B Reactivation in Persons with HIV with Positive Hepatitis B Core Antibody After Switching to Antiretroviral Therapy Without Hepatitis B Activity.”
-
The Latest on Antifungal Vaccines: Updates from IDWeek 2023
13/10/2023Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Stuart M. Levitz, MD Treating fungal infections can be difficult due to the limited treatment options available, but could antifungal vaccines help change that? To catch us up on the progress being made in immunotherapeutic and vaccine strategies, Dr. Charles Turck speaks with Dr. Stuart Levitz about the “Antifungal Vaccines: Where Are We At?” session he presented at IDWeek 2023.
-
What’s New in Infectious Diseases? Takeaways from IDWeek 2023
12/10/2023Host: Jeffrey Freiberg, MD, PhD The field of infectious diseases is always evolving thanks to new research studies, data, and treatment options. To help us catch up on some of these essential updates, Dr. Jeffrey Freiberg is here to give us an overview of the “What's Hot in ID in Clinical Science” session he helped develop for IDWeek 2023.
-
IDWeek 2023: Investigating the Infectious Risk of Xenotransplantation
11/10/2023Host: Jay Fishman, MD With a global shortage of human organs, xenotransplantation offers a potential new way to save lives. But what are the immunologic barriers? Tune in as Dr. Jay Fishman, Director of Transplant Infectious Diseases and Compromised Host Program at Massachusetts General Hospital, recaps his session from the 2023 IDWeek.
-
Study Shows Importance of Comprehensive Genomic Profiling for NSCLC
13/06/2023Guest: Vivek Subbiah, MD This episode will recap updates from the 2023 ASCO Annual Meeting regarding the abstract on comprehensive genomic profiling for non-small cell lung cancer (NSCLC). Join Dr. Vivek Subbiah, Chief of Early Drug Development at the Sarah Cannon Research Institute in Nashville, Tennessee, to learn more.
-
Impact of Infertility & Elective Fertility Among Female Oncologists
09/06/2023Guest: Emily MacDuffie, MD A recent survey conducted by physicians at Penn Medicine found that one-third of female oncologists reported experiencing infertility. Join Dr. Emily Macduffie, Radiation Oncology Resident Physician at Penn Medicine, as she speaks about potential solutions related to infertility for women in medicine based on her 2023 ASCO presentation.
-
Combating the Complexities of Cancer Care During Pregnancy
07/06/2023Guest: Alison Wakoff Loren, MD, MSCE Cancer occurs in approximately 1 in every 1,000 pregnant patients and requires complex solutions from a multidisciplinary team. Learn more about the expanding management options for these patients with Dr. Alison Loren, Chief of the Division of Hematology and Oncology at the University of Pennsylvania Perelman School of Medicine.
-
Diagnosing & Treating Neurocognitive Disorders in the Psychiatric Setting
31/05/2023Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Lokesh Shahani, MD, PhD, MPH, FACP, FASAM Due to their clinical overlap, distinguishing between neurocognitive and psychiatric disorders can be challenging, but an accurate diagnosis is crucial for timely assessment and treatment. Find out how we can better identify and treat complex neurocognitive disorders such as Alzheimer's disease and other forms of dementia with Dr. Charles Turck and Dr. Lokesh Shahani, Associate Professor of Psychiatry and Behavioral Sciences at UT Health Houston McGovern Medical School who presented on this exact topic at the 2023 APA Annual Meeting.
-
Combating Controversies in BPSD Care
30/05/2023Host: Jerome Lisk, MD, MBA, M.S., FAAN Guest: Rajesh Rajagopalan Tampi, MBBS, MS, DFAPA Behavioral and psychological symptoms of dementia (BPSD) refers to a group of noncognitive symptoms that commonly occur in patients with dementia. While data shows efficacy for treatment modalities for these symptoms and behaviors, the use of psychotropic medications has been met with controversy due to their adverse effects. Tune in to hear Dr. Rajesh Tampi, Professor and Chairman of the Department of Psychiatry at Creighton School of Medicine, discuss how we can address those controversies while providing optimal care for our patients, which was the focus of his presentation at the 2023 American Psychiatric Association Annual Meeting.
-
Patients Prefer to Receive Abortion Care via Telemedicine vs In-Clinic Visits
23/05/2023Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Emily M. Godfrey, MD, MPH A recent study presented at the 2023 ACOG Annual Clinical and Scientific Meeting examined patient perspectives on clinician communication regarding medication abortion during telemedicine versus in-clinic visits and found that patients prefer to receive abortion care via telemedicine. Learn more about the study’s design and results with Dr. Charles Turck and Dr. Emily Godfrey, Professor of Family Medicine and Obstetrics and Gynecology at the University of Washington.
-
IUD Reduces Blood Loss by 90% in Patients with Heavy Menstrual Bleeding
23/05/2023Guest: Mitchell D. Creinin, MD Dive into the research presented at the 2023 ACOG Annual Scientific and Clinical Meeting that found that the use of levonorgestrel 52-mg intrauterine device (IUD) in patients with heavy menstrual bleeding reduced blood loss by more than 90 percent over six months with Dr. Mitch Creinin, Professor in the Department of Obstetrics and Gynecology as well as the Director of the Complex Family Planning Fellowship at the University of California Davis Health.
-
Setting Expectations on IUD Expulsion Among Patients with Heavy Menstrual Bleeding
23/05/2023Guest: Mitchell D. Creinin, MD While the use of levonorgestrel 52-mg intrauterine device (IUD) has been shown to reduce blood loss in patients with heavy menstrual bleeding, these same patients are at an increased likelihood of expelling the IUD. That’s why it’s important to set realistic expectations with patients, as Dr. Mitch Creinin from the University of California Davis Health explains.
-
Improving Perinatal Mental Health Management with New Guidelines & Resources
19/05/2023Guest: Tiffany A. Moore Simas, MD, MPH, MEd, FACOG Host: Charles Turck, PharmD, BCPS, BCCCP New guidelines regarding the screening, diagnosis, and pharmacological treatment of perinatal mental health conditions as well as resources like in-depth toolkits and implementation guides are now available to help optimize the management of patients with perinatal mental health conditions. Find out how these tools can help you better address one of the most common complications of pregnancy with Dr. Charles Turck and Dr. Tiffany Moore Simas, the Chair of the Department of Obstetrics and Gynecology at UMass Chan Medical School who presented a few sessions focusing on this exact topic at the 2023 ACOG Annual Clinical and Scientific Meeting.
-
Uncovering Disparities After the Implementation of a Perinatal Depression Intervention
19/05/2023Guest: Tiffany A. Moore Simas, MD, MPH, MEd, FACOG According to a poster that was featured at the 2023 ACOG Annual Clinical and Scientific Meeting, only 75 percent of patients at UMass Chan Medical School were screened for perinatal mental health conditions, and of those screened, white patients were more likely to be connected with appropriate care and treatment than black or Hispanic patients. Dive deeper into the findings that underscore the importance of addressing disparities and inequities in perinatal depression care with Dr. Tiffany Moore Simas, Chair of the Department of Obstetrics and Gynecology at UMass Chan Medical School.
-
Psych Congress 2022: A Look at New Mechanisms of Action in Schizophrenia
19/09/2022Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Craig Chepke, MD, FAPA Although we’ve made some progress in the treatment of schizophrenia, unmet needs still remain. So what are the new mechanism of actions being explored in the treatment of this disease? To learn more about the updates featured at the 2022 Psych Congress, Dr. Charles Turck speaks with Dr. Craig Chepke, Medical Director of Excel Psychiatric Associates and member of the Psych Congress Steering Committee.
-
Crohn's & Colitis Congress 2022: Looking Back & Looking Ahead with the 2023 Chair
21/04/2022Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Peter D. Higgins, MD, PhD What were some of the key takeaways from the 2022 Crohn's & Colitis Congress, and what's in store for next year’s conference? Hear from the incoming 2023 Congress Chair Dr. Peter D. Higgins.
-
Crohn's & Colitis Congress 2022: Combating Challenges for Pediatric Patients
08/04/2022Host: Jennifer Caudle, DO Guest: Ashish S. Patel, MD Treating IBD in our pediatric patients can be challenging, which is why creating a strong partnership between care teams and patients’ families is key. Fortunately, that was a central focus of the 2022 Crohn's & Colitis Congress, so to catch the latest updates and strategies for improving IBD care for pediatric patients, tune in to hear Dr. Jennifer Caudle speak with Dr. Ashish Patel.
-
Crohn's & Colitis Congress 2022: Improving Moderate Ulcerative Colitis Care
01/04/2022Host: Jennifer Caudle, DO Guest: Alan C. Moss, MD, FACG, FEBG, AGAF, FRCPI When patients with moderate ulcerative colitis fail first-line therapy, it's important to know what to do next. And speaking with your patients about their risks and preferences is key. Join us as Dr. Alan Moss shares highlights from his presentation at the 2022 Crohn's & Colitis Congress on treatment considerations for patients with moderate ulcerative colitis.
-
Tracking Transition Readiness & Quality of Life Among Pediatric MS Patients
27/12/2021Host: Jennifer Caudle, DO Guest: Vikram V. Bhise, MD Pediatric multiple sclerosis (MS) occurs in more than 8,000 children in the United States alone, but there’s little data regarding these patients’ quality of life. That’s why Dr. Vikram Bhise recently conducted research to gain a better understanding of pediatric MS patients’ quality of life as they transition into adulthood. And now, Dr. Bhise joins Dr. Jennifer Caudle to share the results that were presented at the 2021 Consortium of Multiple Sclerosis Centers (CMSC) Annual Meeting.
-
A Recap of the Rehabilitation Track at CMSC
16/12/2021Guest: Patty Bobryk, MHS, PT, MSCS, ATP The rehabilitation track at the 2021 Consortium of Multiple Sclerosis Centers (CMSC) was filled with key updates regarding collaboration, nonpharmaceutical symptom management strategies, and more. And Ms. Patty Bobryk, a physical therapist at Yampa Valley Medical Center, is here to review those updates with us.